India weighing Russian offer for Sputnik-V vaccine trial, manufacturing - official | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
June 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, JUNE 02, 2023
India weighing Russian offer for Sputnik-V vaccine trial, manufacturing - official

Coronavirus chronicle

Reuters
08 September, 2020, 05:55 pm
Last modified: 08 September, 2020, 05:54 pm

Related News

  • 1.80 lakh tonnes of fertiliser to come from Russia in FY24
  • Russia’s rupee trap is adding to $147 bln hoard stuck abroad since Ukraine invasion
  • United Indian opposition can beat Modi in 2024: Rahul Gandhi
  • India opposition leader Rahul Gandhi takes a dig at Modi over China in US visit
  • Ukraine says Russia again blocking Black Sea grain export deal

India weighing Russian offer for Sputnik-V vaccine trial, manufacturing - official

"The government of India attaches great importance to this offer of partnership from a friend," said VK Paul, member of the Indian federal government think-tank NITI Aayog

Reuters
08 September, 2020, 05:55 pm
Last modified: 08 September, 2020, 05:54 pm
A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS
A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS

India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" Covid-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said on Tuesday.

"The government of India attaches great importance to this offer of partnership from a friend," said VK Paul, member of the Indian federal government think-tank NITI Aayog.

The outcome of discussions on the offer were expected soon, he added. 

South Asia

India / Russia / Russian Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Budget made on unrealistic assumptions, targets are illusory: CPD
    Budget made on unrealistic assumptions, targets are illusory: CPD
  • Photo: Collected
    Remittance drops in May due to hundi
  • NDB to finance water supply and gas pipeline construction projects in Bangladesh
    NDB to finance water supply and gas pipeline construction projects in Bangladesh

MOST VIEWED

  • Covid is no longer global health emergency: WHO
    Covid is no longer global health emergency: WHO
  • Federal police officers stand guard near the house of former Brazilian President Jair Bolsonaro, during a search operation at his home, in Brasilia, Brazil, 3 May, 2023. REUTERS/Adriano Machado
    Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • World Health Organization logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration//File Photo
    Covid here to stay but moving out of emergency phase: WHO
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India reports 12,591 new Covid cases today, 20% more than yesterday
  • People queue up outside a quick test centre to take their coronavirus disease (Covid-19) antigen rapid tests, in Singapore September 21, 2021. Photo :Reuters
    Singapore witnesses new Covid wave: ‘Cases are mostly mild’
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India logs 5,676 new Covid cases, active infections cross 37,000-mark

Related News

  • 1.80 lakh tonnes of fertiliser to come from Russia in FY24
  • Russia’s rupee trap is adding to $147 bln hoard stuck abroad since Ukraine invasion
  • United Indian opposition can beat Modi in 2024: Rahul Gandhi
  • India opposition leader Rahul Gandhi takes a dig at Modi over China in US visit
  • Ukraine says Russia again blocking Black Sea grain export deal

Features

Photo: Md Adnan Khairullah

Above six thousand metres

19h | Features
Photo: Collected

Al Faya, one grain at a time

20h | Explorer
Illustration: TBS

Runaway non-food inflation remains the bigger culprit, but unchecked

1d | Panorama
There are more than 20 similar shops on Nilkhet footpath that sell tea, biscuits, crockeries, kitchenwares, bedsheets, mats, manicure sets, etc and all carry the logos and marks of different medicines and pharmaceutical companies in Bangladesh. 
Photo: Noor A Alam

Uncovering a treasure trove of pharma co gifts in Nilkhet's footpaths

2d | Panorama

More Videos from TBS

Budget reflects IMF conditions

Budget reflects IMF conditions

1h | TBS Economy
Awarness and vaccination can prevent cervical cancer

Awarness and vaccination can prevent cervical cancer

2h | TBS Health
Prices up, prices down

Prices up, prices down

17h | TBS Economy
6% inflation rate highly ambitious: Selim Raihan

6% inflation rate highly ambitious: Selim Raihan

17h | TBS Economy

Most Read

1
bKash denied permission to pay $4.10 lakh for Argentina football partnership
Banking

bKash denied permission to pay $4.10 lakh for Argentina football partnership

2
File Photo: Mohammad Minhaj Uddin/TBS
Bangladesh

Low-cost housing planned for 4 lakh Bangabandhu Shilpa Nagar workers

3
Boeing offers Biman its latest 787-10 Dreamliner
Bangladesh

Boeing offers Biman its latest 787-10 Dreamliner

4
Country's first floating solar power plant connected to national grid
Energy

Country's first floating solar power plant connected to national grid

5
Govt to double gain tax on land, flat registration
Budget

Govt to double gain tax on land, flat registration

6
Photo: TBS
Environment

Green space in Dhaka North declines 66% in 3 decades: Study

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]